FERTIN PHARMA A/S: Financial statements 2021
CVR: 25834844
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
FERTIN PHARMA A/S (CVR 25834844) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 932,545,000 and a net result of DKK 37,642,000 compared with DKK 155,411,000 the year before. That is a decrease of 5.9% compared with the year before. The profit margin was 4%. Equity in the 2021 report amounted to DKK 681,404,000. The solvency ratio was 33.7%. The company had 569 employees in the financial year.
- Revenue
- DKK 932,545,000
- Gross Profit
- DKK 161,384,000
- Profit/Loss
- DKK 37,642,000
- Equity
- DKK 681,404,000
- Total Assets
- DKK 2,021,489,000
- Employees
- 569
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 932.5M | 161.4M | 37.6M | 681.4M | 569 |
| 2020 | 991.1M | 246.4M | 155.4M | 770.1M | 674 |
| 2019 | 881.6M | 190.8M | 81.3M | 778.3M | 661 |
| 2018 | 812.5M | 121.4M | 45.8M | 896M | 609 |
| 2017 | 867.7M | 208.5M | 106.4M | 770.5M | 572 |
Official annual report
Find more companies like FERTIN PHARMA A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of September 15, 2021, Michael Henrik Thomsen has joined the board of directors of FERTIN PHARMA A/S.
As of September 15, 2021, Peter Andreas Lund Dahl Jacobsen has joined the board of directors of FERTIN PHARMA A/S.
As of September 15, 2021, Peter Halling has joined the board of directors of FERTIN PHARMA A/S.
As of September 15, 2021, Lene Lind has joined the board of directors of FERTIN PHARMA A/S.
As of September 15, 2021, Lars Bang has left the board of directors of FERTIN PHARMA A/S.
As of September 15, 2021, Claus Bagger-Sørensen has left the board of directors of FERTIN PHARMA A/S.
As of September 15, 2021, Rikke Kjær Nielsen has left the board of directors of FERTIN PHARMA A/S.
As of September 15, 2021, Manfred Scheske has left the board of directors of FERTIN PHARMA A/S.
As of September 15, 2021, Frank Charles Condella Jr has left the board of directors of FERTIN PHARMA A/S.
As of September 15, 2021, Carsten Skou has left the board of directors of FERTIN PHARMA A/S.
About FERTIN PHARMA A/S
FERTIN PHARMA A/S is a Danish company of the type Aktieselskab based in Vejle, founded in 2001. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named JUT NR. 2128 A/S. The management consists of Michael Henrik Thomsen. The board consists of Christopher Beck Lambert (chair), Bo Korsgaard Jensen, Jovana Mejri and Michael Henrik Thomsen. The company is owned by Aspeya Inc.. The company has 959 employees (2026). In 2025, the company reported revenue of DKK 1,344,394,000 and a net result of DKK -280,841,000 compared with DKK -259,011,000 the year before. Equity in the 2025 report amounted to DKK 1,269,900,000.
